Health

The selection of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS) has sparked considerable criticism among health policy experts. Wendell Primus, a distinguished visiting fellow at the Brookings Schaeffer Initiative on Health Policy, articulated significant concerns regarding this appointment. Many observers fear that Kennedy’s past statements and positions could

Ventricular tachycardia (VT) presents significant challenges, particularly in patients with ischemic cardiomyopathy. Recent findings from the VANISH2 trial have prompted a reconsideration of the standard treatment protocols, showcasing that catheter ablation may be more effective than starting therapy with antiarrhythmic drugs. This article delves into the implications of these findings, evaluates the trial’s methodology, and

Metastatic urothelial carcinoma (mUC) presents a formidable challenge in oncology, characterized by the spread of cancer cells from the bladder to other parts of the body. Traditional therapies often fall short of delivering satisfactory long-term responses, making the introduction of targeted therapies pivotal in altering the treatment landscape. One such innovation is enfortumab vedotin (Padcev),

Recent reports highlight notable concerns in the American healthcare landscape, underscoring the complex interplay of disease, healthcare access, and medical ethics. The alarming statistic that fewer than 50% of responding psychiatric hospitals are providing medications for opioid use disorder comes from a survey of over a thousand institutions. This gap in care underscores the systemic

The crisis of drug overdose deaths in the United States has been a topic of grave concern for decades. However, recent statistics suggest a possible turning point in this ongoing epidemic. Provisional data by the Centers for Disease Control and Prevention (CDC) indicates a significant drop in overdose-related deaths, sparking both cautious optimism and the

As the United States transitions into a new political landscape with the advent of a new administration and Congress, it becomes crucial to address the pressing need for reform in the healthcare system, particularly concerning primary care. Primary care serves as the backbone of the healthcare system, but it has faced significant challenges that threaten

Hypertrophic cardiomyopathy (HCM) represents one of the most frequently inherited forms of heart disease, characterized by an abnormal thickening of the heart muscle. This condition can present significant challenges for clinicians pursuing an accurate diagnosis due to its symptoms often overlapping with other conditions that cause left ventricular hypertrophy (LVH). Recent research has focused on

The landscape of kidney cancer treatment has evolved significantly, with minimally invasive techniques gaining a prominent place in the therapeutic arsenal. One such approach is ablative therapy, a method that targets tumors with focused energy to destroy cancerous cells without the need for extensive surgery. However, recent findings have raised alarms regarding the efficacy of

The American Medical Association (AMA) plays a critical role in representing physicians across the United States. However, a growing concern has emerged about whether the House of Delegates (HOD) has become too large to function effectively. In his recent address, outgoing AMA CEO Dr. James Madara raised this pertinent issue, prompting an essential reflection on

Axial spondyloarthritis (axSpA) represents a complex group of inflammatory rheumatic diseases that primarily affect the spine and sacroiliac joints, leading to chronic pain and stiffness. This condition can manifest in two forms: radiographic axSpA, which is commonly recognized as ankylosing spondylitis, and non-radiographic axSpA. Although both versions present similar clinical pictures, therapeutic strategies may differ